This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Isabelle Andrée Lucette Treilleux
Introduction
Isabelle Andrée Lucette Treilleux is a notable inventor based in Lyons, France. He has made significant contributions to the field of cancer research, particularly in the area of prognosis and diagnosis. His work is aimed at improving clinical decision-making for cancer treatment.
Latest Patents
Treilleux holds a patent for "Methods for cancer prognosis and diagnosis." This invention provides methods for prognosis and diagnosis in human cancer patients by detecting the infiltration of certain immune cells in human tumor tissues. These immune cells are associated with poor cancer prognosis. The methods developed by Treilleux are useful for making informed clinical decisions regarding cancer treatment, surveillance, and surgical intervention. He has 1 patent to his name.
Career Highlights
Treilleux is affiliated with Schering Corporation, where he applies his expertise in cancer research. His work has been instrumental in advancing the understanding of cancer prognosis and the role of immune cells in tumor environments.
Collaborations
He has collaborated with notable colleagues, including Jean-Yves Guy Christophe Blay and Jean-Jacques Pin. These collaborations have further enriched his research and contributions to the field.
Conclusion
Isabelle Andrée Lucette Treilleux's innovative work in cancer prognosis and diagnosis highlights the importance of research in improving patient outcomes. His contributions are paving the way for advancements in cancer treatment and clinical decision-making.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile